(Press-News.org) Scientists have observed, for the first time, an intermediate stage in the chemical process that repairs DNA methylation damage and regulates many important biological functions that impact health conditions such as obesity, cancer and diabetes.
The observations focused on the bacterial DNA repair protein AlkB, but the results also apply to several proteins in the same family that play key regulatory roles in humans. Armed with these results, researchers may one day develop methods for blocking the protein's efforts to perform the biologically important demethylation function in human cells, said Chuan He, Professor in Chemistry at the University of Chicago.
"This family of proteins is the most exciting protein family now in biology," said He, who led the study. "These proteins directly impact obesity, cancer and diabetes, and they do not go through the traditional pathways of DNA or protein modification. Most likely they go through RNA modification and demodification. It's a new area of biological research."
He and his colleagues at UChicago and the University of Wisconsin-Madison report their findings in the journal Nature, published online on Nov. 10.
The Nature article presents new details about how proteins chemically alter biological molecules and their functioning via a process called oxidative demethylation. Methylation is a chemical process that helps control how DNA and other proteins carry out their functions in the body. In the case of DNA, methylation and demethylation affect how the genetic code gets made into proteins. In recent years scientists had assumed that AlkB and related proteins initiate an oxidizing reaction to remove a hydrocarbon group (the methyls) from the group's host molecule.
"Biological methylation is one of the most important processes in nature to regulate all kinds of things," He said, including how cells differentiate into their final state and how genetic information is transmitted to proteins.
The UChicago researchers recently invented a chemical technique to trap the AlkB protein when it reacts with its host molecule — a previously unobserved, ephemeral process. The technique tethers the protein to the host molecule. "It's stuck there. It can react and stop at the intermediate stage," He said.
Bizarre Observation
Two of the enzymatic intermediates that He's team trapped and observed were predicted and expected based on the chemical principles involved, but these fleeting species were directly observed for the first time. For a third intermediate, however, "we observed something bizarre," He said.
Researchers at UW-Madison then carried out computational calculations on the electronic and structural properties of the intermediates that He observed in his experiments. The calculations showed that the bizarrely behaving intermediate was "zwitterionic," meaning that it carried an overall neutral charge, but displayed positive or negative charges when interacting with different atoms.
"We were able to show that the intermediate captured by Chuan's beautiful experiment is zwitterionic in nature, which offers new clues regarding the chemical steps of the biological demethylation process," said Qiang Cui, professor of chemistry at UW-Madison.
The team documented the role of oxidation in demethylation using the U.S. Department of Energy's Advanced Photon Source at Argonne National Laboratory. The APS produces the brightest X-rays in the Western Hemisphere, which permitted the team to determine the crystal structures that show the three-dimensional atomic framework of the intermediate stage in the demethylation process.
Members of He's research team visit the APS two or three times a month for a full day of experimentation. "We literally collected close to a hundred data sets there," He said. The researchers take multiple data sets at different intervals to confirm the accuracy of their results.
INFORMATION:
The National Institutes of Health supported this study.
DNA repair protein caught in act of molecular theft
2010-11-11
ELSE PRESS RELEASES FROM THIS DATE:
Trojan Horse ploy to sneak protective drug into brains of stroke patients
2010-11-11
Scientists are reporting development of a long-sought method with the potential for getting medication through a biological barrier that surrounds the brain, where it may limit the brain damage caused by stroke. Their approach for sneaking the nerve-protective drug erythropoietin into the brain is medicine's version of the Trojan Horse ploy straight out of ancient Greek legend. It also could help people with traumatic head injuries, Parkinson's disease, and other chronic brain disorders. Their report appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.
William ...
Soft drink could enhance effects of an anticancer drug
2010-11-11
Experiments with an artificial stomach suggest that a popular lemon-lime soft drink could play an unexpected role in improving the effectiveness of an oral anticancer drug. The experiments produced evidence that patients will absorb more of the unnamed drug, tested in Phase I in clinical trials, when taken with "flat" or degassed Sprite. The study appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.
Faraj Atassi and colleagues note that efforts are underway to develop more anticancer medications that patients can take by mouth. However, biological variations ...
U of A researchers can predict heart transplant patient's health earlier
2010-11-11
Michael Mengel, a pathology researcher with the Faculty of Medicine & Dentistry, has found a new way to analyze biopsies from heart transplant patients by looking at their genes. This allows him to make an early prediction whether the transplant is working.
This is extremely important in heart transplant patients because a successful outcome depends completely on doing a biopsy of the heart tissue and prescribing treatments if necessary. In other organs transplants, doctors can use other measurements.
It's hoped the new technology and process developed in the Faculty ...
Guardian angels for seeds
2010-11-11
The seeds that you plant in your backyard garden next spring — and farmers sow in their fields — may have a guardian angel that helps them sprout, stay healthy, and grow to yield bountiful harvests. It's a thin coating of chemicals termed a "seed treatment" that can encourage seeds to germinate earlier in the season, resist insects and diseases, and convey other advantages. These new seed defenders are the topic of an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
C&EN Senior Business Editor Melody Voith describes a boom ...
Stress takes its toll in Parkinson's disease
2010-11-11
CHICAGO --- We all know that living a stressful lifestyle can take its toll, making us age faster and making us more susceptible to the cold going around the office.
The same appears to be true of neurons in the brain. According to a new Northwestern Medicine study published Nov. 10 in the journal Nature, dopamine-releasing neurons in a region of the brain called the substantia nigra lead a lifestyle that requires lots of energy, creating stress that could lead to the neurons' premature death. Their death causes Parkinson's disease.
"Why this small group of neurons ...
New neuronal circuits which control fear have been identified
2010-11-11
Fear is an adaptive response, essential to the survival of many species. This behavioural adaptation may be innate but can also be a consequence of conditioning, during the course of which an animal learns that a particular stimulus precedes an unpleasant event. There is a large amount of data indicating that the amygdala, a particular structure in the brain, is strongly involved during the learning of "conditioned" fear. However, until now, the underlying neuronal circuits have remained largely unknown. Now, research involving several Swiss and German teams and a researcher ...
Researchers see ethical dilemmas of providing care in drug detention centers
2010-11-11
(Garrison, NY) Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?
Such dilemmas are explored in an article coauthored by Nancy Berlinger and Michael Gusmano, research scholars at The Hastings Center, along with Roxanne Saucier and Daniel Wolfe of the Open Society Institute, and Nicholas Thomson ...
Circuit regulating anti-diabetic actions of serotonin uncovered by UT Southwestern researchers
2010-11-11
DALLAS – Nov. 11, 2010 – New findings by researchers at UT Southwestern Medical Center suggest that serotonin – a brain chemical known to help regulate emotion, mood and sleep – might also have anti-diabetic properties.
The findings, appearing online this week in Nature Neuroscience, also offer a potential explanation for why individuals prescribed certain kinds of anti-psychotic drugs that affect serotonin signaling sometimes have problems with their metabolism, including weight gain and the development of diabetes.
"In this paper, we describe a circuit in the brain ...
News tips from a special issue of the International Journal of Plant Sciences
2010-11-11
The November/December issue of the International Journal of Plant Sciences explores the current state of our knowledge of natural selection in plants.
"Plants were crucially important to Darwin's development of the theory of natural selection (six of his books were on plants)," writes Jeffrey Conner, a biologist at Michigan State University and guest editor of the issue. "Plants are still crucially important to the study of natural selection in the field."
The issue features reviews and original research articles that explore multiple aspects of this complex topic. ...
Caltech scientists describe the delicate balance in the brain that controls fear
2010-11-11
PASADENA, Calif.—The eerie music in the movie theater swells; the roller coaster crests and begins its descent; something goes bump in the night. Suddenly, you're scared: your heart thumps, your stomach clenches, your throat tightens, your muscles freeze you in place. But fear doesn't come from your heart, your stomach, your throat, or your muscles. Fear begins in your brain, and it is there—specifically in an almond-shaped structure called the amygdala—that it is controlled, processed, and let out of the gate to kick off the rest of the fear response.
In this week's ...